These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25212028)

  • 1. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
    Niu F; Li Y; Lai FF; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.
    Ball AT; Mohammed S; Doigneaux C; Gardner RM; Easton JW; Turner S; Essex JW; Pairaudeau G; Tavassoli A
    J Am Chem Soc; 2024 Apr; 146(13):8877-8886. PubMed ID: 38503564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
    Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
    Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.
    Yu T; Tang B; Sun X
    Yonsei Med J; 2017 May; 58(3):489-496. PubMed ID: 28332352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway.
    Manolescu B; Oprea E; Busu C; Cercasov C
    Biochimie; 2009; 91(11-12):1347-58. PubMed ID: 19703512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.
    Mooring SR; Jin H; Devi NS; Jabbar AA; Kaluz S; Liu Y; Van Meir EG; Wang B
    J Med Chem; 2011 Dec; 54(24):8471-89. PubMed ID: 22032632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of hypoxia-inducible factor-1 signaling.
    Belozerov VE; Van Meir EG
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1067-76. PubMed ID: 17209524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective.
    Bhattarai D; Xu X; Lee K
    Med Res Rev; 2018 Jul; 38(4):1404-1442. PubMed ID: 29278273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the mitochondria for cancer therapy: regulation of hypoxia-inducible factor by mitochondria.
    Bell EL; Klimova T; Chandel NS
    Antioxid Redox Signal; 2008 Mar; 10(3):635-40. PubMed ID: 17999628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1 signaling in drug resistance to chemotherapy.
    Warfel NA; El-Deiry WS
    Curr Med Chem; 2014; 21(26):3021-8. PubMed ID: 24735366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer therapy by targeting hypoxia-inducible factor-1.
    Li Y; Ye D
    Curr Cancer Drug Targets; 2010 Nov; 10(7):782-96. PubMed ID: 20578983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
    Brahimi-Horn C; Pouysségur J
    Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
    Chen MC; Hsu WL; Hwang PA; Chou TC
    Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor (HIF) in human tumorigenesis.
    Mabjeesh NJ; Amir S
    Histol Histopathol; 2007 May; 22(5):559-72. PubMed ID: 17330811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
    Albadari N; Deng S; Li W
    Expert Opin Drug Discov; 2019 Jul; 14(7):667-682. PubMed ID: 31070059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.